We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-12.38%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$735M
AUM Growth
-$144M
Cap. Flow
-$17.5M
Cap. Flow %
-2.37%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$1.26M

Top Sells

Rank Stock Value
1
ORIC icon
Oric Pharmaceuticals
ORIC
+$18.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$273M 37.08%
15,396,116
– –
TNYA icon
2
Tenaya Therapeutics
TNYA
$163M
$178M 24.23%
9,400,290
– –
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$84.3M 11.46%
3,347,245
– –
SRZN icon
4
Surrozen
SRZN
$282M
$60.6M 8.25%
627,653
+11,111
+2% +$1.26M
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.44B
$52.5M 7.13%
3,568,181
-1,200,000
-25% -$18.7M
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$51.5M 7%
175,251
– –
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$35.7M 4.85%
172,373
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q4 2021 Portfolio in Review

As of Q4 2021, Column Group held 7 positions worth $735M, down 16% from $879M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group added most to Surrozen in Q4 2021, an estimated $1.26M increase.
  • Column Group's biggest Q4 2021 reduction was Oric Pharmaceuticals, cutting an estimated $18.7M.
  • Column Group's ten largest holdings make up 100% of its $735M portfolio in Q4 2021.
  • Column Group opened 0 new positions and closed 0 in Q4 2021.
  • Column Group's portfolio value fell 16% quarter-over-quarter to $735M.

Based on Column Group's 13F filing for Q4 2021, filed 11 Feb 2022.